C-erbB-2 in Serum of Patients with Breast Cancer

Overview of attention for article published in The International Journal of Biological Markers, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 358)
Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 12 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

Marker for inducing EGFR targeted therapy resistance and use thereof

Application KR-20230029551-A

Republic of Korea

Composition for predicting drug responsiveness after EGFR targeted therapy drug holiday

Application KR-20230029552-A

Republic of Korea

Composition for detecting EGFR targeted therapy resistance and screening method for…

Application KR-20230029140-A

Republic of Korea

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272

Grant US-10729672-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 8 additional patents.